日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3

Brexucabtagene autoleucel 用于 BTKi 初治复发/难治性套细胞淋巴瘤:ZUMA-2 队列 3 的主要分析

van Meerten, Tom; Kersten, Marie José; Iacoboni, Gloria; Hess, Georg; Mutsaers, Pim; García-Sancho, Alejandro Martín; Goy, Andre; Giné, Eva; Hill, Brian T; Weng, Wen-Kai; Reagan, Patrick M; Patel, Krish; Galal, Ahmed; Herbaux, Charles; Sanderson, Robin; Forcade, Edouard; Topp, Max S; Houot, Roch; Zheng, Dan; Zhang, Wangshu; Kanska, Justyna; Shen, Rhine R; Damico Khalid, Rita; Kloos, Ioana; Dreyling, Martin; Wang, Michael L

BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma

BrECADD 与 BEACOPP 方案对晚期霍奇金淋巴瘤患者健康相关生活质量的影响

Ferdinandus, Justin; Müller, Horst; Jablonski, Janina; Kerkhoff, Andrea; Scholl, Sebastian; Ko, Yon-Dschun; Topp, Max S; Vucinic, Vladan; Jung, Wolfram; Schroers, Roland; Rank, Andreas; Fuchs, Michael; Schneider, Gundolf; Diehl, Volker; Borchmann, Peter; Behringer, Karolin

Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for multiple myeloma

接受T细胞激活疗法治疗的多发性骨髓瘤患者中,低度感染负担沉重。

Mersi, Julia; Burow, Lara; Zhou, Xiang; Eisele, Florian; Fante, Matthias; Riedhammer, Christine; Stich, August; Isberner, Nora; Afrin, Nazia; Duell, Johannes; Topp, Max S; Einsele, Hermann; Waldschmidt, Johannes; Kortüm, K Martin; Rasche, Leo

Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study

奥德罗内西他单药治疗CAR-T细胞疗法进展后的复发/难治性弥漫性大B细胞淋巴瘤:ELM-1研究的主要分析

Topp, Max S; Matasar, Matthew; Allan, John N; Ansell, Stephen M; Barnes, Jeffrey A; Arnason, Jon E; Michot, Jean-Marie; Goldschmidt, Neta; O'Brien, Susan M; Abadi, Uri; Avivi, Irit; Cheng, Yuan; Flink, Dina M; Zhu, Min; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Crombie, Jennifer L

Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy

内皮功能障碍和促炎状态决定了CAR-T疗法的严重血液毒性和不良疗效。

Scheller, Lukas; Zhou, Xiang; Loeffler-Wirth, Henry; Kreuz, Markus; Kadel, Sofie-Katrin; Schimanski, Sven; Schulze, Hannah; Ruckdeschel, Anna; Eisele, Florian; Konetzki, Verena; Jornet Culubret, Maria; Merz, Maximilian; Mersi, Julia; Waldschmidt, Johannes; Danhof, Sophia; Köhl, Ulrike; Kortüm, K Martin; Rasche, Leo; Einsele, Hermann; Düll, Johannes; Topp, Max S; Hudecek, Michael; Reiche, Kristin; Alb, Miriam

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

ZUMA-3 研究对接受 brexucabtagene autoleucel 治疗的复发或难治性 B 细胞急性淋巴细胞白血病成年患者进行了为期三年的分析

Shah, Bijal D; Cassaday, Ryan D; Park, Jae H; Houot, Roch; Logan, Aaron C; Boissel, Nicolas; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; O'Dwyer, Kristen M; Tzachanis, Dimitrios; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C; Wierda, William G; DeAngelo, Daniel J; Stiff, Patrick; Jeyakumar, Deepa; Mao, Daqin; Adhikary, Sabina; Zhou, Lang; Hadjivassileva, Tsveta; Damico Khalid, Rita; Ghobadi, Armin; Oluwole, Olalekan O

Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement

CAR-T细胞和双特异性抗体在伴有髓外侵犯的多发性骨髓瘤中的活性

Steinhardt, Maximilian J; Schaefers, Christoph; Leypoldt, Lisa B; Blau, Igor-Wolfgang; Harzer, Marie; Zhou, Xiang; Riedhammer, Christine; Kamili, Abdulaziz; Kosch, Ricardo; Topp, Laura S; Molwitz, Isabel; Gross-Fengels, Nils-Ole; Melzer, Yasmin Fede; Artzenroth, Jule; Al-Bazaz, Maximilian; Alsdorf, Winfried; Topp, Max S; Duell, Johannes; Mersi, Julia; Waldschmidt, Johannes; Bokemeyer, Carsten; Einsele, Hermann; Kortüm, K Martin; Weisel, Katja; Rasche, Leo

Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement

更正:CAR-T细胞和双特异性抗体在髓外侵犯的多发性骨髓瘤中的活性

Steinhardt, Maximilian J; Schaefers, Christoph; Leypoldt, Lisa B; Blau, Igor-Wolfgang; Harzer, Marie; Zhou, Xiang; Riedhammer, Christine; Kamili, Abdulaziz; Kosch, Ricardo; Topp, Laura S; Molwitz, Isabel; Gross-Fengels, Nils-Ole; Melzer, Yasmin Fede; Artzenroth, Jule; Al-Bazaz, Maximilian; Alsdorf, Winfried; Topp, Max S; Duell, Johannes; Mersi, Julia; Waldschmidt, Johannes; Bokemeyer, Carsten; Einsele, Hermann; Kortüm, K Martin; Weisel, Katja; Rasche, Leo

Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma

桥接强度与多发性骨髓瘤 BCMA CAR-T 疗法后造血功能恢复受损相关

Frenking, Jan H; Zhou, Xiang; Rejeski, Kai; Wagner, Vivien; Costello, Patrick; Hielscher, Thomas; Gatti, Lilan; Kauer, Joseph; Nadeem, Omar; Mai, Elias K; Michel, Christian S; Friedrich, Mirco J; Sedloev, David; Weinhold, Niels; Goldschmidt, Hartmut; Herfarth, Klaus; Schmitt, Anita; Hundemer, Michael; Schmitt, Michael; Müller-Tidow, Carsten; Topp, Max; Einsele, Hermann; Dreger, Peter; Munshi, Nikhil C; Sperling, Adam S; Rasche, Leo; Sauer, Sandra; Raab, Marc S

Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy

CD19和CD20靶向T细胞重定向治疗后淋巴瘤的抗原丢失和分支演变

Duell, Johannes; Leipold, Alexander M; Appenzeller, Silke; Fuhr, Viktoria; Rauert-Wunderlich, Hilka; Da Via, Matteo; Dietrich, Oliver; Toussaint, Christophe; Imdahl, Fabian; Eisele, Florian; Afrin, Nazia; Grundheber, Lars; Einsele, Hermann; Weinhold, Niels; Rosenwald, Andreas; Topp, Max S; Saliba, Antoine-Emmanuel; Rasche, Leo